Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors – Results of a Prospective Biomarker Study

PURPOSE: BRAF and MEK inhibitors significantly improved the prognosis of metastatic melanoma. Nevertheless, initial treatment response may be only temporary. Liquid biopsies (LB) offer a possibility to monitor patients by measuring circulating tumor DNA (ctDNA). We sought to find out whether ctDNA c...

Descripción completa

Detalles Bibliográficos
Autores principales: Forschner, Andrea, Weißgraeber, Stephanie, Hadaschik, Dirk, Schulze, Martin, Kopp, Maria, Kelkenberg, Sabine, Sinnberg, Tobias, Garbe, Claus, Biskup, Saskia, Battke, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280255/
https://www.ncbi.nlm.nih.gov/pubmed/32581559
http://dx.doi.org/10.2147/OTT.S248237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280255/
https://www.ncbi.nlm.nih.gov/pubmed/32581559
http://dx.doi.org/10.2147/OTT.S248237

Ejemplares similares